Literature DB >> 17471115

Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations.

Jesse K McKenney1, Amy Heerema-McKenney, Robert V Rouse.   

Abstract

Extragonadal germ cell tumors (GCTs) are relatively uncommon, but represent 1% to 5% of all GCTs. Their morphology varies widely and includes mature teratoma, immature teratoma, seminoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, and mixed GCTs. Noncentral nervous system extragonadal GCTs are found in a variety of anatomic locations, but most commonly affect the mediastinum and sacrococcygeal region. Predicting behavior in these tumors can be confusing because it is based on a combination of varying factors including patient age, histologic subtype, anatomic site, and clinical stage. This review attempts to dissect these issues by separating the discussion into 3 age groups: neonatal (congenital), children (prepubertal), and adult (postpubertal). Within each individual age group, we cover the significance of anatomic site, morphology, and staging parameters. In addition, we discuss the spectrum of associated secondary malignancies and their impact on patient outcome. Finally, we provide a detailed survey of differential diagnostic considerations grouped by anatomic site.

Entities:  

Mesh:

Year:  2007        PMID: 17471115     DOI: 10.1097/PAP.0b013e31803240e6

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  52 in total

1.  A case of primary retroperitoneal teratoma presenting as an adrenal incidentaloma.

Authors:  R Giordano; G Giraudo; D Forno; M Bosco; L Delsedime; M Morino; E Arvat
Journal:  J Endocrinol Invest       Date:  2011-09       Impact factor: 4.256

2.  Mature and Immature Solid Teratomas Involving Uterine Corpus, Cervix, and Ovary.

Authors:  Simona Stolnicu; Emoke Szekely; Calin Molnar; Claudiu V Molnar; Iulia Barsan; Valeria D'Alfonso; Cosmin Moldovan; Gang Zheng; Brigitte M Ronnett; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2017-05       Impact factor: 2.762

3.  Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.

Authors:  H Gui; R A Kolster; M B Palmer; J S Brooks; M Zhang; M A Husson
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

4.  Neuroendocrine carcinoma arising within a retroperitoneal mature teratoma.

Authors:  Alice L Scott; Nima Abbassi-Ghadi; Charles M G Archer; Rajiv Swamy; Sanjay Gupta
Journal:  Ann R Coll Surg Engl       Date:  2010-06-23       Impact factor: 1.891

5.  Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.

Authors:  Jenny J Ko; Tehmina Asif; Haocheng Li; Nimira Alimohamed; Phuong Thao Nguyen; Daniel Y C Heng
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

6.  Mediastinal seminoma presenting with superior vena cava syndrome.

Authors:  Amanda Wanous; Ian R McPhail; J Fernando Quevedo; Nicole P Sandhu
Journal:  BMJ Case Rep       Date:  2017-06-08

7.  Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.

Authors:  Pavlos Msaouel; Miao Zhang; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2016-09-07       Impact factor: 2.872

8.  Primary choriocarcinoma of the liver: a clinicopathological study of five cases in males.

Authors:  Huaiyin Shi; Dengfeng Cao; Lixin Wei; Lu Sun; Aitao Guo
Journal:  Virchows Arch       Date:  2009-12-16       Impact factor: 4.064

9.  [Congenital esophageal duplication cysts: progressive dysphagia in adulthood].

Authors:  M M Gilg; P Swatek; A Lutfi; F Smolle-Jüttner; C Langner
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

10.  Primary seminoma arising in the middle mediastinum: A case report.

Authors:  Jing Xu; Jinglan Zhao; Shaoqing Geng; Q I Wang; Pengfei Wang; Chunling Zhang; Xiongzeng Zhu; Youxin Ji
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.